2020
Efficacy, rate of tumor response, and safety of a short course (12-24聽weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial.
Journal of the American Academy of Dermatology
鈥�
2020
Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study.
Journal of the European Academy of Dermatology and Venereology : JEADV
鈥�
2019
Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014.
JAMA otolaryngology-- head & neck surgery
鈥�
2019
Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.
Transplant international : official journal of the European Society for Organ Transplantation
鈥�
